Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Patients with schizophrenia at risk for excessive antipsychotic dosing.

Walkup JT, McAlpine DD, Olfson M, Labay LE, Boyer C, Hansell S.

J Clin Psychiatry. 2000 May;61(5):344-8.

PMID:
10847308
2.

Long-acting injectable antipsychotics in the elderly: guidelines for effective use.

Masand PS, Gupta S.

Drugs Aging. 2003;20(15):1099-110. Review.

PMID:
14651433
3.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients..

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

4.

Dosing of quetiapine in schizophrenia: how clinical practice differs from registration studies.

Citrome L, Jaffe A, Levine J, Lindenmayer JP.

J Clin Psychiatry. 2005 Dec;66(12):1512-6. Review.

PMID:
16401150
5.

Antipsychotic medication: clinical guidelines for maintenance therapy.

Johnson DA.

J Clin Psychiatry. 1985 May;46(5 Pt 2):6-15. Review.

PMID:
2859281
6.

Strategies for dosing and switching antipsychotics for optimal clinical management.

Buckley PF, Correll CU.

J Clin Psychiatry. 2008;69 Suppl 1:4-17. Review.

7.

Good medical practice in antipsychotic pharmacotherapy.

Peuskens J.

Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S35-41. Review.

PMID:
9690969
8.

Dose response of prophylactic antipsychotics.

Davis JM, Kane JM, Marder SR, Brauzer B, Gierl B, Schooler N, Casey DE, Hassan M.

J Clin Psychiatry. 1993 Mar;54 Suppl:24-30. Review.

PMID:
8097195
9.

Depot neuroleptics: a comparative review of standard, intermediate, and low-dose regimens.

Kane JM, Woerner M, Sarantakos S.

J Clin Psychiatry. 1986 May;47 Suppl:30-3. Review.

PMID:
2871014
10.

Depot antipsychotic drugs. Place in therapy.

Davis JM, Matalon L, Watanabe MD, Blake L, Metalon L [corrected to Matalon L].

Drugs. 1994 May;47(5):741-73. Review. Erratum in: Drugs 1994 Oct;48(4):616.

PMID:
7520856
11.

Oral antipsychotic update: a brief review of new and investigational agents for the treatment of schizophrenia.

Citrome L.

CNS Spectr. 2012 Nov;17 Suppl 1:1-9. doi: 10.1017/S1092852912000727. Review.

PMID:
23448847
12.

[Depot antipsychotics in the year 2011].

Knegtering H, Oolders H, Ruijsink MA, van der Moolen AE.

Tijdschr Psychiatr. 2011;53(2):95-105. Review. Dutch.

13.

Influences on therapist's decisions for neuroleptic treatment in schizophrenia: the role of characteristics of the patient and the physician.

Franz M, Ranger J, Hanewald B, Gallhofer B, Lay B.

Pharmacopsychiatry. 2012 Nov;45(7):261-8. doi: 10.1055/s-0032-1312609. Epub 2012 May 30. Review.

PMID:
22648306
14.

Pharmacotherapy of schizophrenia: the American current status.

Shen WW.

Keio J Med. 1994 Dec;43(4):192-200. Review.

15.

[The "neuroleptic threshold"--a review of the literature].

Abraham D, Kissling W, Lauter H.

Psychiatr Prax. 1996 May;23(3):109-16. Review. German.

PMID:
8710999
16.

Depot neuroleptic therapy: clinical considerations.

Remington GJ, Adams ME.

Can J Psychiatry. 1995 Apr;40(3 Suppl 1):S5-11. Review.

PMID:
7627927
17.

Antipsychotic dosing: how much but also how often?

Remington G, Kapur S.

Schizophr Bull. 2010 Sep;36(5):900-3. doi: 10.1093/schbul/sbq083. Epub 2010 Jul 21. Review.

18.

Reducing dosage in maintenance treatment of schizophrenia. Review and prognosis.

Schooler NR.

Br J Psychiatry Suppl. 1993 Dec;(22):58-65. Review.

PMID:
7906525
19.

Practice parameter for the assessment and treatment of children and adolescents with schizophrenia.

McClellan J, Stock S; American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI)..

J Am Acad Child Adolesc Psychiatry. 2013 Sep;52(9):976-90. doi: 10.1016/j.jaac.2013.02.008. Review.

20.

Antipsychotic dosing: extended, and transient.

Seeman P, Remington G.

Clin Schizophr Relat Psychoses. 2012 Jul;6(2):86-7. doi: 10.3371/CSRP.6.2.6. Review. No abstract available.

PMID:
22776635

Supplemental Content

Support Center